3-(3-chlorophenyl)-2-cyclohexyl-10-methylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione

ID: ALA4756486

PubChem CID: 4901726

Max Phase: Preclinical

Molecular Formula: C24H22ClN3O2

Molecular Weight: 419.91

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1c2ccccc2c(=O)c2c(=O)n(-c3cccc(Cl)c3)c(C3CCCCC3)nc21

Standard InChI:  InChI=1S/C24H22ClN3O2/c1-27-19-13-6-5-12-18(19)21(29)20-23(27)26-22(15-8-3-2-4-9-15)28(24(20)30)17-11-7-10-16(25)14-17/h5-7,10-15H,2-4,8-9H2,1H3

Standard InChI Key:  FWEQAEDOKUQTFO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   26.2880   -2.8238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2869   -3.6509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0014   -4.0636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9996   -2.4113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7147   -2.8202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7154   -3.6467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4305   -4.0575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.4249   -2.4062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1405   -2.8133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1441   -3.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8629   -4.0522    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5786   -3.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5709   -2.8014    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8516   -2.3954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4205   -1.5815    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8443   -1.5708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2759   -2.3833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9943   -2.7905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7041   -2.3721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6966   -1.5466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9736   -1.1414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2667   -1.5621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2913   -4.0400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2953   -4.8656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0084   -5.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7219   -4.8586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7179   -4.0330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0003   -3.6214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4219   -2.7780    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   28.4326   -4.8822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  8  5  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
  8 15  2  0
 14 16  2  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 13 17  1  0
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 12 23  1  0
 19 29  1  0
  7 30  1  0
M  END

Associated Targets(Human)

DRD5 Tchem Dopamine D5 receptor (1597 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.91Molecular Weight (Monoisotopic): 419.1401AlogP: 4.94#Rotatable Bonds: 2
Polar Surface Area: 56.89Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 5.51CX LogD: 5.51
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.43Np Likeness Score: -1.01

References

1. Luderman KD,Jain P,Benjamin Free R,Conroy JL,Aubé J,Sibley DR,Frankowski KJ.  (2021)  Development of pyrimidone D1 dopamine receptor positive allosteric modulators.,  31  [PMID:33221389] [10.1016/j.bmcl.2020.127696]

Source